Position in RCUS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$13,052,373
+$4,114,769 QoQ
Shares Held
423,366
+2.3% QoQ
Ownership
0.332%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#39
of 230 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. RCUS ranks #32 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in RCUS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,052,373 | 423,366 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $8,937,604 | 413,778 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $9,711,033 | 407,513 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $4,549,526 | 334,524 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $2,736,870 | 336,225 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,629,600 | 334,981 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $3,923,767 | 263,517 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $3,908,292 | 255,611 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $4,178,928 | 274,388 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $5,474,538 | 289,965 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $6,356,746 | 332,814 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $5,913,483 | 329,442 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $6,664,319 | 328,130 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $5,923,256 | 324,740 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $6,803,864 | 329,007 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $8,925,948 | 341,206 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $8,407,228 | 331,777 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $262,326 | 8,312 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $347,232 | 8,580 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $490,934 | 14,079 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $449,300 | 16,362 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $657,464 | 23,414 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $625,116 | 24,080 | Shares | Defined | 2021-02-23 | |
| No filing history on record for this holder in this stock. | ||||||